January/February 2015 Issue
PCI Synthesis’ 2015 Forecast sees the Biotech sector on the extremes
The supply chain for genuine pharmaceuticals has grown longer, and every step in the chain offers an opportunity for counterfeiters.
Emerging technologies plus standardized process can deliver competitive agility to lab operations
CPV must be implemented as a system, complete with a strategy and plan for implementation and sustainability throughout the lifecycle of the process/product
VerGo employs Stat-Ease Inc., software to design optimal three-factor experiment
Redesigned is the New Skinny
Insightful integration of Contract Manufacturing Organizations into clinical trial business
Pharmaceutical processors have begun to wield some new tools, nailing down new efficiencies and better drugs in the process.
Fewer headaches, reduced complexity and flexibility come with the territory
Confident application of process analytical technologies is creating a blizzard of operational benefits for drug makers
Drug Owners and CMOs both have skin in the game when it comes to specifying bioreactor technology